跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lozarphil Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lozarphil Plus
Approved
STANDARD
Lozarphil Plus
Mediwin Pharmaceuticals
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
18266068b9411cac
Company
Mediwin Pharmaceuticals
Type
Standard
Approval Details
Approval Id
18266068b9411cac
Drug Approval Philippines Name
Lozarphil Plus
Product Name
Lozarphil Plus
Registration Number
DRP-4690-01
Brand Name
Lozarphil Plus
Generic Name
Losartan Potassium + Hydrochlorithiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg/12.5 mg
Manufacturer
Mediwin Pharmaceuticals
Importer
Ambica International Trading Corp.
Distributor
Phil Asia Pharma, Inc.
Issuance Date
27 October 2022
Expiry Date
06 September 2028
Pharmacologic Category
Angiotensin-II-Receptor Blocker / Diuretic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
18266068b9411cac
Type
Standard
Back to Philippines FDA Approvals